Rating Change
BMO Capital reiterated its Outperform rating on The Chemours Company (NYSE:CC) on August 13, 2026.
reiterateNYSE:CC
BMO Capital Reiterates Outperform Rating on The Chemours Company (CC)
BMO Capital reiterated its Outperform rating on The Chemours Company (NYSE:CC) on August 13, 2026.
At publication ·
What changed
The Chemours Company (NYSE:CC) · reiterate
- Firm
- BMO Capital
- Rating
- Outperform to Outperform
- Price at event
- $15.26
- Market capitalization
- $2.0B
At a glance
Key takeaways
- BMO Capital reiterated an Outperform rating on Chemours (CC) on August 13, 2026, with the stock trading at $15.26 and a market capitalization of $2.0 billion.
Market Context
The Chemours Company operates in the Basic Materials sector. The stock currently trades at $15.26 with a market capitalization of $2.0B. The stock has gained 1.9% over the past 52 weeks.
Analyst coverage from BMO Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for The Chemours Company.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for The Chemours Company
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 13, 2026 | JP Morgan | Neutral | N/A |
| Aug 13, 2026 | BMO Capital | Outperform | N/A |
| Aug 10, 2026 | UBS | Neutral | N/A |
| Aug 06, 2026 | Truist Securities | Buy | N/A |
| Aug 06, 2026 | RBC Capital | Outperform | N/A |
Related Tools: Analyst Ratings Dashboard | View CC Stock Page
Frequently Asked Questions
What does the Outperform rating mean for CC?
A rating of Outperform from BMO Capital reflects the analyst's outlook on The Chemours Company (NYSE:CC). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the CC forecast page.